Details for: RPL34P18

Gene ID: 100271003

Gene Type:  Pseudogene  - A non-functional segment of DNA that resembles a functional gene but has lost its protein-coding ability or is otherwise no longer expressed.

Symbol: RPL34P18

Ensembl ID: ENSG00000240509

Description: ribosomal protein L34 pseudogene 18

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 23.59
    rCSI 18.9%
    PRS 98.57
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 14
    rCSI 21.82%
    PRS 99.7
  • professional antigen presenting cell CL0000145
    CSI 8.14
    rCSI 28.04%
    PRS 99.17
  • primordial germ cell CL0000670
    CSI 7.55
    rCSI 37.73%
    PRS 98.79

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [RPL34P18](/details-gene/100271003) is a pseudogene located on chromosome 8q22.1, identified as a non-protein-coding homolog of the ribosomal protein L34 gene. Despite its classification as a pseudogene, its transcript is expressed with high significance in specific cell populations. **Overall**, expression data indicate a notable enrichment in developing T lymphocytes, including [CD4-positive, alpha-beta thymocyte](/details-cell/CL0000810) and [CD8-positive, alpha-beta thymocyte](/details-cell/CL0000811). This expression pattern suggests that, while not translated into a protein, the [RPL34P18](/details-gene/100271003) transcript may have a regulatory role or serve as a specific marker for cellular processes occurring during T cell maturation in the thymus. ## Cellular Roles and Expression Landscape The expression profile of [RPL34P18](/details-gene/100271003) points towards a specialized role in highly proliferative and developmental contexts. Its highest significance scores are found in thymocytes, with a Cell Significance Index (CSI) of 23.59 in [CD4-positive, alpha-beta thymocyte](/details-cell/CL0000810) and 14.00 in [CD8-positive, alpha-beta thymocyte](/details-cell/CL0000811). This strong association with T cell precursors suggests a potential involvement in the molecular events governing T cell development, selection, or proliferation within the thymic microenvironment. Beyond the thymus, [RPL34P18](/details-gene/100271003) also shows significant expression in [professional antigen presenting cell](/details-cell/CL0000145) (CSI: 8.14) and [primordial germ cell](/details-cell/CL0000670) (CSI: 7.55). Its presence in these distinct, yet highly specialized cell types, hints at a possible function related to fundamental cellular processes such as proliferation or differentiation, rather than a function limited to a single lineage. The fact that a pseudogene transcript is maintained at such significant levels in these specific cells suggests it may not be mere transcriptional noise but could possess a currently uncharacterized biological function. ## Pathways and Molecular Function As a pseudogene of Ribosomal Protein L34, [RPL34P18](/details-gene/100271003) is not predicted to be translated into a functional protein component of the ribosome. Therefore, its biological activity, if any, is likely mediated at the RNA level. Modern genomics research has revealed that many pseudogene transcripts can function as long non-coding RNAs (lncRNAs) with regulatory roles. One plausible mechanism is that the [RPL34P18](/details-gene/100271003) transcript acts as a competing endogenous RNA (ceRNA). In this capacity, it could bind to and "sponge" microRNAs, thereby preventing them from inhibiting their other target mRNAs. This could indirectly regulate the expression of its parent gene, [RPL34](/details-gene/6164), or other genes involved in ribosome biogenesis and cell growth, processes that are critically active in developing thymocytes. Currently, there are no formal functional annotations from databases like GO or Reactome for [RPL34P18](/details-gene/100271003), underscoring its status as an uncharacterized gene. ## Research Directions The specific and significant expression of the [RPL34P18](/details-gene/100271003) pseudogene in key developmental cell types presents several intriguing avenues for future research. The central question is whether its expression is a functional component of cellular regulation or simply a byproduct of transcriptional activity in these cells. **Proposed Hypotheses:** 1. [RPL34P18](/details-gene/100271003) functions as a regulatory lncRNA essential for normal T cell development. Its transcript may modulate the stability or translation of key mRNAs involved in thymocyte proliferation or selection by acting as a microRNA sponge. 2. The transcription of [RPL34P18](/details-gene/100271003) is not functionally significant in itself but acts as a highly specific biomarker for the metabolic state of rapid proliferation and high translational demand characteristic of developing thymocytes and germ cells. **Experimental Approach:** To test the hypothesis that [RPL34P18](/details-gene/100271003) has a regulatory function in T cell development, a loss-of-function study could be performed. One could use antisense oligonucleotides (ASOs) to specifically degrade the [RPL34P18](/details-gene/100271003) transcript in an in vitro model of human thymocyte differentiation from hematopoietic stem cells. The impact of the knockdown on the progression through key developmental checkpoints (e.g., the transition from double-negative to double-positive stages) would be quantified using flow cytometry. Subsequent RNA-sequencing of knockdown and control cells would reveal downstream transcriptional changes and could clarify whether [RPL34P18](/details-gene/100271003) regulates its parent gene [RPL34](/details-gene/6164) or other critical T cell development pathways. **Therapeutic Potential:** The therapeutic potential of [RPL34P18](/details-gene/100271003) is currently speculative but holds promise if a functional role is established. Given its restricted expression pattern, it represents a potentially specific target. If its expression is found to be aberrantly high in hematological malignancies like T-cell acute lymphoblastic leukemia (T-ALL) and contributes to the disease phenotype, it could become a target for therapeutic inhibition using RNA-based drugs like ASOs. Such a strategy would likely have a favorable safety profile due to the gene's limited expression in other major tissues.